HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P H Edelstein Selected Research

Legionnaires' Disease (Legionnaire's Disease)

11/2001BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
10/2001In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
8/2001In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P H Edelstein Research Topics

Disease

3Legionnaires' Disease (Legionnaire's Disease)
11/2001 - 08/2001
3Infections
10/2001 - 03/2000
1Cross Infection (Nosocomial Infection)
01/2013
1Body Weight (Weight, Body)
10/2001
1Pneumonia (Pneumonitis)
08/2001

Drug/Important Bio-Agent (IBA)

2beta-Lactamases (beta-Lactamase)IBA
10/2001 - 04/2001
1garenoxacinIBA
11/2001
1FluoroquinolonesIBA
10/2001
1cethromycinIBA
10/2001
1Virulence Factors (Pathogenicity Factors)IBA
08/2001
1Gemifloxacin (Factive)FDA Link
08/2001
1PhosphoenolpyruvateIBA
08/2001
1Phosphotransferases (Kinase)IBA
08/2001
1Anti-Bacterial Agents (Antibiotics)IBA
04/2001
1IronIBA
03/2000

Therapy/Procedure

3Therapeutics
01/2013 - 08/2001
1Length of Stay
04/2001